Evaluate the impact of HAT therapy versus placebo in the treatment of patients with an acute NSTI and sepsis.
Primary outcome:
Secondary outcomes:
Condition | Necrotizing Soft Tissue Infection, Sepsis |
---|---|
Treatment | Placebo, HAT, HAT |
Clinical Study Identifier | NCT05157360 |
Sponsor | Ascension Via Christi Hospitals Wichita, Inc. |
Last Modified on | 2 February 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.